search
Back to results

Efficacy and Safety of Topical Diclofenac Combined With Oral Diclofenac in the Treatment of Knee Osteoarthritis

Primary Purpose

Osteoarthritis, Knee

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Diclofenac, topical
Sponsored by
Nuvo Research Inc.
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis, Knee focused on measuring topical NSAID, topical diclofenac

Eligibility Criteria

40 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Primary osteoarthritis of the knee, verified radiographically Moderate flare of pain in the knee after washout of stable therapy If female, non-pregnant Ability to swallow moderately-sized tablets Exclusion Criteria: Secondary osteoarthritis of the knee Major knee surgery at any time, or minor knee surgery in previous year Severe uncontrolled heart, liver or kidney disease Ulcer or bleeding from the stomach Corticosteroid use Fibromyalgia Skin disorder of the knee

Sites / Locations

  • Coastal Clinical Research
  • Redpoint Research
  • OMC Clinical
  • Associated Pharmaceutical Research
  • Med Investigators
  • Desert Medical Advances
  • Boling Clinical Trials
  • Tampa Bay Medical Research Inc.
  • Palm Beach Research Center
  • Medisphere Medical Research
  • Synergy Medical Education Alliance
  • Redrock Research Center
  • Partners in Primary Care
  • Camp Hill Clinical Research Center
  • Primary Physicians Research
  • University Orthopedics Center
  • Omega Medical Research
  • Clinical Research Associates
  • Research Across America
  • Sam Clinical Research Center
  • Hamptom Roads Center for Clinical Research
  • National Clinical Research

Outcomes

Primary Outcome Measures

pain
physical function
patient overall health assessment

Secondary Outcome Measures

stiffness
patient global assessment

Full Information

First Posted
April 21, 2005
Last Updated
January 4, 2007
Sponsor
Nuvo Research Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT00108992
Brief Title
Efficacy and Safety of Topical Diclofenac Combined With Oral Diclofenac in the Treatment of Knee Osteoarthritis
Study Type
Interventional

2. Study Status

Record Verification Date
January 2007
Overall Recruitment Status
Completed
Study Start Date
February 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
September 2005 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Nuvo Research Inc.

4. Oversight

5. Study Description

Brief Summary
Oral non-steroidal anti-inflammatory drugs (NSAIDs) are a recommended treatment for the symptoms of osteoarthritis of the knee. However, NSAIDs may cause a range of negative side effects, including stomach pain, heartburn, bleeding stomach ulcer, and liver or kidney abnormality. A topical NSAID may relieve pain and other symptoms of osteoarthritis of the knee, while minimizing the side effects common to oral NSAIDs. The purpose of this study is to determine the safety and effectiveness of a topical NSAID when used alone or when combined with an oral NSAID in the treatment of osteoarthritis of the knee.
Detailed Description
During this 12-week study, patients will visit the study clinic 5 times. At the screening visit, the patient's demographic information, medical and medication history will be recorded and a physical examination performed. After washout of all NSAIDs/other analgesic medication, the patient will return for the baseline visit. During the treatment phase of the study, the patient will apply a topical solution to his/her osteoarthritic knee and take an oral study tablet. The patient may randomly receive active treatment with topical diclofenac, oral diclofenac, both, or neither (placebo). Follow-up clinic visits are conducted at 4, 8 and 12 weeks. Routine laboratory analyses are done at baseline, 4 and 12 weeks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Knee
Keywords
topical NSAID, topical diclofenac

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
750 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Diclofenac, topical
Primary Outcome Measure Information:
Title
pain
Title
physical function
Title
patient overall health assessment
Secondary Outcome Measure Information:
Title
stiffness
Title
patient global assessment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Primary osteoarthritis of the knee, verified radiographically Moderate flare of pain in the knee after washout of stable therapy If female, non-pregnant Ability to swallow moderately-sized tablets Exclusion Criteria: Secondary osteoarthritis of the knee Major knee surgery at any time, or minor knee surgery in previous year Severe uncontrolled heart, liver or kidney disease Ulcer or bleeding from the stomach Corticosteroid use Fibromyalgia Skin disorder of the knee
Facility Information:
Facility Name
Coastal Clinical Research
City
Mobile
State/Province
Alabama
ZIP/Postal Code
36608
Country
United States
Facility Name
Redpoint Research
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85029
Country
United States
Facility Name
OMC Clinical
City
Beverly Hills
State/Province
California
ZIP/Postal Code
90211
Country
United States
Facility Name
Associated Pharmaceutical Research
City
Buena Park
State/Province
California
ZIP/Postal Code
90620
Country
United States
Facility Name
Med Investigators
City
Fair Oaks
State/Province
California
ZIP/Postal Code
95628
Country
United States
Facility Name
Desert Medical Advances
City
Palm Desert
State/Province
California
ZIP/Postal Code
92260
Country
United States
Facility Name
Boling Clinical Trials
City
Upland
State/Province
California
ZIP/Postal Code
91786
Country
United States
Facility Name
Tampa Bay Medical Research Inc.
City
Clearwater
State/Province
Florida
ZIP/Postal Code
33761
Country
United States
Facility Name
Palm Beach Research Center
City
West Palm Beach
State/Province
Florida
ZIP/Postal Code
33409
Country
United States
Facility Name
Medisphere Medical Research
City
Evansville
State/Province
Indiana
ZIP/Postal Code
47714
Country
United States
Facility Name
Synergy Medical Education Alliance
City
Saginaw
State/Province
Michigan
ZIP/Postal Code
48602
Country
United States
Facility Name
Redrock Research Center
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89146
Country
United States
Facility Name
Partners in Primary Care
City
Voorhees
State/Province
New Jersey
ZIP/Postal Code
08043
Country
United States
Facility Name
Camp Hill Clinical Research Center
City
Camp Hill
State/Province
Pennsylvania
ZIP/Postal Code
17011
Country
United States
Facility Name
Primary Physicians Research
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15241
Country
United States
Facility Name
University Orthopedics Center
City
State College
State/Province
Pennsylvania
ZIP/Postal Code
16801
Country
United States
Facility Name
Omega Medical Research
City
Warwick
State/Province
Rhode Island
ZIP/Postal Code
02886
Country
United States
Facility Name
Clinical Research Associates
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37203
Country
United States
Facility Name
Research Across America
City
Dallas
State/Province
Texas
ZIP/Postal Code
75234
Country
United States
Facility Name
Sam Clinical Research Center
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
Facility Name
Hamptom Roads Center for Clinical Research
City
Norfolk
State/Province
Virginia
ZIP/Postal Code
23502-9921
Country
United States
Facility Name
National Clinical Research
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23294
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Efficacy and Safety of Topical Diclofenac Combined With Oral Diclofenac in the Treatment of Knee Osteoarthritis

We'll reach out to this number within 24 hrs